These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 26299326)
1. Anticancer drugs induce hypomethylation of the acetylcholinesterase promoter via a phosphorylated-p38-DNMT1-AChE pathway in apoptotic hepatocellular carcinoma cells. Xi Q; Gao N; Yang Y; Ye W; Zhang B; Wu J; Jiang G; Zhang X Int J Biochem Cell Biol; 2015 Nov; 68():21-32. PubMed ID: 26299326 [TBL] [Abstract][Full Text] [Related]
2. A natural antisense transcript regulates acetylcholinesterase gene expression via epigenetic modification in Hepatocellular Carcinoma. Xi Q; Gao N; Zhang X; Zhang B; Ye W; Wu J; Zhang X Int J Biochem Cell Biol; 2014 Oct; 55():242-51. PubMed ID: 25240585 [TBL] [Abstract][Full Text] [Related]
3. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721. Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis. Long XR; He Y; Huang C; Li J Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846 [TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization. Zhao Y; Wang X; Wang T; Hu X; Hui X; Yan M; Gao Q; Chen T; Li J; Yao M; Wan D; Gu J; Fan J; He X Hepatology; 2011 Feb; 53(2):493-503. PubMed ID: 21274871 [TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis. Deng R; Li W; Guan Z; Zhou JM; Wang Y; Mei YP; Li MT; Feng GK; Huang W; Liu ZC; Han Y; Zeng YX; Zhu XF Oncogene; 2006 Nov; 25(53):7070-7. PubMed ID: 16715131 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation. Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422 [TBL] [Abstract][Full Text] [Related]
9. Gene induction and apoptosis in human hepatocellular carci-noma cells SMMC-7721 exposed to 5-aza-2'-deoxycytidine. Fan H; Zhao ZJ; Cheng YC; Shan YF; Lu ZH; Zhang JQ; Xie W Chin Med J (Engl); 2007 Sep; 120(18):1626-31. PubMed ID: 17908484 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells. Cheng JC; Auersperg N; Leung PC Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells. Fan H; Zhao Z; Cheng Y; Cui H; Qiao F; Wang L; Hu J; Wu H; Song W Tumour Biol; 2016 Jan; 37(1):877-85. PubMed ID: 26254611 [TBL] [Abstract][Full Text] [Related]
12. Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer. Lu L; Zhang X; Zhang B; Wu J; Zhang X Int J Biochem Cell Biol; 2013 Nov; 45(11):2530-40. PubMed ID: 23974008 [TBL] [Abstract][Full Text] [Related]
13. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433 [TBL] [Abstract][Full Text] [Related]
14. DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8. Kurita S; Higuchi H; Saito Y; Nakamoto N; Takaishi H; Tada S; Saito H; Gores GJ; Hibi T Cancer Sci; 2010 Jun; 101(6):1431-9. PubMed ID: 20398055 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic and biological significance of DNA methyltransferase 1 upregulated by growth factors in human hepatocellular carcinoma. Fang QL; Yin YR; Xie CR; Zhang S; Zhao WX; Pan C; Wang XM; Yin ZY Int J Oncol; 2015 Feb; 46(2):782-90. PubMed ID: 25420499 [TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status. Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509 [TBL] [Abstract][Full Text] [Related]
17. CAPE promotes TRAIL-induced apoptosis through the upregulation of TRAIL receptors via activation of p38 and suppression of JNK in SK-Hep1 hepatocellular carcinoma cells. Kim EY; Ryu JH; Kim AK Int J Oncol; 2013 Oct; 43(4):1291-300. PubMed ID: 23857473 [TBL] [Abstract][Full Text] [Related]
18. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. Chen W; Gao N; Shen Y; Cen JN J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341 [TBL] [Abstract][Full Text] [Related]
19. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma. Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332 [TBL] [Abstract][Full Text] [Related]
20. Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721. Zhao QZ; Dou KF J Gastroenterol Hepatol; 2007 May; 22(5):683-9. PubMed ID: 17444856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]